In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Opsona Therapeutics and Phylogica Drug Discovery Collaboration
Innovative Partnership Targets Cancer-causing 'Chaperones'
PHYLOGICA AND DYNAMIC MICROBIALS SIGN ANTI-BACTERIAL DEAL
PHYLOGICA ENTERS ANTI-MICROBIAL FIELD
Isis, Lilly expand collaboration into cancer drugs
Teva, Technion to develop anti-cancer drugs
Desitin and G2M Cancer Drugs sign development agreement on novel cancer treatment
Affymetrix Extends Collaborations in Cancer Research Program to North America